4/A: AIM ImmunoTech Director Acquires Shares in Lieu of Compensation

Director William M Mitchell acquires 43,330 shares of AIM ImmunoTech Inc. in lieu of director compensation.

Summary

• On February 14, 2025, William M Mitchell, a director of AIM ImmunoTech Inc., acquired 43,330 shares of common stock at a price of $0.1202 per share.
• These shares were issued in lieu of director compensation under the company's Cash Conservation Plan.
• Following the transaction, Mitchell directly owns 241,393 shares of AIM ImmunoTech Inc.
• Mitchell also has indirect ownership of 190 shares through a spouse and trusts.

Sentiment

Score: 6

Explanation: The sentiment is neutral. A director acquiring shares is generally positive, but the context of 'in lieu of compensation' suggests potential cash constraints at the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
• The Cash Conservation Plan allows the company to preserve cash while still compensating directors.

Industry Context

Directors often receive shares as part of their compensation, aligning their interests with those of shareholders. This is a common practice in publicly traded companies.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively.
• The Cash Conservation Plan may impact director compensation structure.

Key Dates

Keywords

AIM ImmunoTech Inc., Director Compensation, Share Acquisition, Form 4, Beneficial Ownership, Mitchell William M, Cash Conservation Plan